It's probably a complicated question... But with each reading, what are the kinds of issues that are being debated? I would have thought by the third reading, things would have been addressed. I guess we can expect the same level of debate (disagreement?) when it lands in the Senate?
- Forums
- ASX - By Stock
- KPO
- Ann: Regulatory & Project Development Update
Ann: Regulatory & Project Development Update, page-140
Featured News
Add KPO (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $30.13M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $1.914K | 169.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 259675 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 1650000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 259675 | 0.011 |
5 | 2703538 | 0.010 |
4 | 1297822 | 0.009 |
2 | 575000 | 0.007 |
1 | 55000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 1650000 | 1 |
0.013 | 17918 | 1 |
0.014 | 319269 | 3 |
0.015 | 1563771 | 2 |
0.016 | 1106687 | 3 |
Last trade - 15.58pm 12/11/2024 (20 minute delay) ? |
Featured News
KPO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online